Genesis Drug Discovery & Development News and Activities

Headquarters: United States (USA)

Genesis Drug Discovery & Development is owned by Genesis Biotechnology Group.

They are in:

View the org chart displaying its 10 main executives

Create your alert
to follow the executive moves at Genesis Drug Discovery & Development.

Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

The best decision-maker directory

Discover the organization charts of your favorite companies.

Spot the influential executives using our search tools.

Receive notifications when executive positions change.

Fuel your company's success with our real-time data.

Individual Access

Data & API

Executives

Companies

The Official Board